It has been demonstrated that some SALL1 truncating variants were resistant to nonsense-mediated decay in TBS-patient fibroblasts and EBV-transformed B-cells, supporting the hypothesis that expression of a truncated protein is critical in the pathogenesis of TBS [16, 19]. This evidence concerns the gene SALL1 and Townes-Brocks syndrome.